Tech Company Financing Transactions
Vantage Oncology Funding Round
Vantage Oncology closed a $7.7 million Series B funding round on 6/23/2004. Investors included New Enterprise Associates.
Transaction Overview
Company Name
Announced On
6/23/2004
Transaction Type
Venture Equity
Amount
$7,700,000
Round
Series B
Investors
New Enterprise Associates (Lead Investor) (Charles Linehan)
Proceeds Purpose
The funds will be used for new cancer treatment facilities and to further operational developments.
Company Information
Company Status
Acquired or Merged
Industry
Healthcare Services
Mailing Address
1500 Rosecrans Avenue 400
Mahattan Beach, CA 90266
USA
Mahattan Beach, CA 90266
USA
Phone
Website
Email Address
Overview
Vantage Oncology develops and operates state-of-the-art radiation oncology centers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Fiore
Chief Financial Officer
Marshal Salomon
Chief Medical Officer
Leslie Botnick
Chief Technical Officer
Christopher Rose
Controller
Joe Chang
VP - General Counsel
Steve Udicious
VP - Operations
Richard Daversa
VP - Operations
Milton Hinkle
Browse more venture capital transactions:
Prev: 6/23/2004: Emphasys Medical venture capital transaction
Next: 6/23/2004: Konarka Technologies venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs